Brief: PhaseBio Pharmaceuticals And SFJ Pharmaceuticals Announce Approval Of IND Application In China For Bentracimab
10/08/2021 14:58
Aug 10 (Reuters) - PhaseBio Pharmaceuticals Inc PHAS.O :
* PHASEBIO PHARMACEUTICALS AND SFJ PHARMACEUTICALS® ANNOUNCE
APPROVAL OF IND APPLICATION IN CHINA FOR BENTRACIMAB
* PHASEBIO PHARMACEUTICALS INC - ENROLLMENT IN REVERSE-IT
GLOBAL
PHASE 3 TRIAL FROM CLINICAL SITES IN CHINA EXPECTED TO BEGIN
LATER IN 2021
Source text for Eikon: ID:nBw1TcSHca
Further company coverage: PHAS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on PhaseBio Pharmaceuticals
See all newsBrief: Phasebio Pharmaceuticals Says Bankruptcy Court Entered Order Approving 1st Amended Combined Disclosure Statement & Chapter 11 Plan On Final Basis
U.S. RESEARCH ROUNDUP- Entegris, FedEx, Kellogg
U.S. RESEARCH ROUNDUP- Armstrong World Industries, Eli Lilly, Netflix
U.S. STOCKS ON THE MOVE-TransDigm, Vaxcyte, Tricida
PhaseBio Pharma slips on bankruptcy plans